Source: Sovereign Wealth Fund Institute

Vivodyne: Khosla Ventures Bets on Growing Human Tissues to Test New Therapies with Vivodyne Investment

Philadelphia-based Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials. The company was founded in 2021 at the University of Pennsylvania by Bioengineering PhD Andrei Georgescu and Associate Professor of Bioengineering Dan Huh. Vivodyne's platform was originally developed at Penn in the BIOLines Laboratory. Vivodyne...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Andrei Georgescu's photo - Co-Founder & CEO of Vivodyne

Co-Founder & CEO

Andrei Georgescu

CEO Approval Rating

90/100

Read more